RecruitingNCT05410457

Different Treatment Strategies on Prognosis of Acute Ischemic Stroke(AISDTS)

Study on the Effect of Different Treatment Strategies on Prognosis of Acute Ischemic Stroke(AISDTS)


Sponsor

Nanjing First Hospital, Nanjing Medical University

Enrollment

5,000 participants

Start Date

May 24, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

AISDTS is a prospective registry study, in which clinical information, examination and imaging data of patients with acute ischemic stroke receiving different treatment strategies were collected, grouped and statistically analyzed, and corresponding clinical prediction models were constructed to explore the role of clinical biological indicators in the occurrence and development of stroke.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • A) ≥18 years of age; B) hospital admission for ischemic stroke; C) Signed informed consent.

Exclusion Criteria1

  • A) patients with incomplete clinical information; B) hospitalization observation time less than 24 hours; C) recent trauma, severe inflammation, severe liver and kidney dysfunction, progressive malignance and other serious diseases; D) baseline mRS score\>2; E) informed consent is not signed.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Nanjing First Hospital, Nanjing Medical University

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05410457


Related Trials